Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12,397 GBX | +0.30% | +1.92% | +16.98% |
06:21am | HBM Holdings Unit, AstraZeneca Sign License, Option Agreement for Targeted Cancer Treatment; Shares Rise 16% | MT |
May. 22 | Behind the numbers: AstraZeneca aims for sales of $80 billion by 2030 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.98% | 244B | |
+39.06% | 723B | |
+34.19% | 595B | |
-2.76% | 369B | |
+19.89% | 332B | |
+2.19% | 282B | |
+9.54% | 208B | |
-4.91% | 205B | |
+1.11% | 168B | |
+6.45% | 166B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- LumiraDx to Partner With AstraZeneca, Everton Charity Arm For Heart And Lung Screening Hub